World's Best Scientists 2026 revealed!
Richard Vandlen

Richard Vandlen

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
20438
World Ranking
11710
National Ranking
5035

Overview

Richard Vandlen is affiliated with Genentech in the United States and has contributed to several research areas primarily within biochemistry, genetics, molecular biology, medicine, and immunology and microbiology. Their work intersects multiple subfields including molecular biology, radiology, nuclear medicine and imaging, oncology, immunology, and molecular medicine.

Their research covers a variety of topics focusing on monoclonal and polyclonal antibodies research, antibiotic resistance in bacteria, bacterial biofilms and quorum sensing, bacteriophages and microbial interactions, protein purification and stability, microfluidic and capillary electrophoresis applications, as well as chemical synthesis and analysis.

Recent publications by Richard Vandlen include:

  • Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate, 2021, mBio
  • Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibody, 2022, mAbs
  • Discovery of a dual pathway aggregation mechanism for a therapeutic constrained peptide, 2021, Journal of Pharmaceutical Sciences
  • MHC2-SCALE enhances identification of immunogenic neoantigens, 2025, iScience
  • Mechanistic Characterization of the Potency of THIOMAB Antibody-Drug Conjugates Targeting Staphylococcus aureus and ETbR-Expressing Tumor Cells Using Quantitative LC-MS/MS Analysis of Intracellular Drug Accumulation, 2025, Bioconjugate Chemistry

Richard Vandlen has frequently collaborated with several coauthors including Kimberly K. Kajihara, Hilda Hernández-Barry, Kelly M. Loyet, Thomas H. Pillow, and Wouter L. W. Hazenbos. This collaborative pattern emphasizes engagement across multiple aspects of antibody research and biochemical methodologies.

Their work has appeared in diverse peer-reviewed journals, highlighting a broad publication record in:

  • mBio
  • mAbs
  • Journal of Pharmaceutical Sciences
  • iScience
  • Bioconjugate Chemistry

Best Publications

  • Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

    Jagath R Junutula;Helga Raab;Suzanna Clark;Sunil Bhakta

  • Characterization of a multicomponent receptor for GDNF

    James J. S. Treanor;Laurie Goodman;Frederic de Sauvage;Donna M. Stone

  • Identification of heregulin, a specific activator of p185erbB2.

    William E. Holmes;Mark X. Sliwkowski;Robert W. Akita;William J. Henzel

  • Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates

    Ben-Quan Shen;Keyang Xu;Luna Liu;Helga Raab

  • The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency

    Bruce A. Keyt;Lea T. Berleau;Hung V. Nguyen;Helen Chen

  • Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

    M.X. Sliwkowski;G. Schaefer;R.W. Akita;J.A. Lofgren

  • Novel antibody–antibiotic conjugate eliminates intracellular S. aureus

    Sophie M. Lehar;Thomas Pillow;Min Xu;Leanna Staben

  • Cysteine engineered antibodies and conjugates

    Charles W. Eigenbrot;Jagath Reddy Junutula;Henry Lowman;Helga E. Raab

  • Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

    Ling Fu;Linu M. John;Sean H. Adams;Xing Xian Yu

  • Persephin, a Novel Neurotrophic Factor Related to GDNF and Neurturin

    Jeffrey Milbrandt;Frederic J de Sauvage;Timothy J Fahrner;Robert H Baloh

  • Spatial control of EGF receptor activation by reversible dimerization on living cells

    Inhee Chung;Robert Akita;Richard Vandlen;Derek Toomre

  • IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1

    James Lee;Wei-Hsien Ho;Miko Maruoka;Racquel T. Corpuz

  • Decreased food intake does not completely account for adiposity reduction after ob protein infusion.

    N Levin;C Nelson;A Gurney;R Vandlen

  • A GPI-linked Protein That Interacts With Ret to Form a Candidate Neurturin Receptor

    Robert D. Klein;Robert D. Klein;Daniel Sherman;Wei-Hsien Ho;Donna Stone

  • The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment

    Hilary F. Clark;Austin L. Gurney;Evangeline Abaya;Kevin Baker

  • Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer.

    Jagath R. Junutula;Kelly M. Flagella;Richard A. Graham;Kathryn L. Parsons

  • Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

    Andrew G. Polson;Jill Calemine-Fenaux;Pamela Chan;Wesley Chang

  • High-Level Expression and Characterization of a Purified 142-Residue Polypeptide of the Prion Protein†

    I Mehlhorn;D Groth;J Stöckel;B Moffat

  • Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin

    Ashley E. Fouts;Pamela Chan;Jean-Philippe Stephan;Richard Vandlen

  • IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp.

    Guohua Pan;Phillip Risser;Weiguang Mao;Daryl T. Baldwin

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Richard Vandlen

Trending Scientists